Evidence map›Paper›PMID 36798671›Full record

ArticlePathology oncology research : POR2023

Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer.

Gábor Rubovszky, Judit Kocsis, Katalin Boér, Nataliya Chilingirova, Magdolna Dank, Zsuzsanna Kahán, Dilyara Kaidarova, Erika Kövér, Bibiana Vertáková Krakovská, Károly Máhr and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Gábor RubovszkyDepartment of Clinical Pharmacology, National Institute of Oncology, Chest and Abdominal Tumours Chemotherapy "B", Budapest, Hungary.
Judit KocsisCenter of Oncoradiology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary.
Katalin BoérDepartment of Oncology, Szent Margit Hospital, Budapest, Hungary.
Nataliya ChilingirovaClinic Center of Excellence, Heart and Brain Hospital, Science and Research Institute, Medical University-Pleven, Pleven, Bulgaria.
Magdolna DankOncology Centre, Semmelweis University, Budapest, Hungary.
Zsuzsanna KahánOncotherapy Clinic, University of Szeged, Szeged, Hungary.
Dilyara KaidarovaKazakh Institute of Oncology and Radiology, Almaty, Kazakhstan.
Erika KövérInstitute of Oncotherapy, Faculty of Medicine, University of Pécs, Pécs, Hungary.
Bibiana Vertáková Krakovská1st Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Károly MáhrDepartment of Oncology, Szent Rafael Hospital of Zala County, Zalaegerszeg, Hungary.
Bela Mriňáková1st Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Béla PikóCounty Oncology Centre, Pándy Kálmán Hospital of Békés County Council, Gyula, Hungary.
Ivana Božović-SpasojevićInstitute for Oncology and Radiology of Serbia, Daily Chemotherapy Hospital, Belgrade, Serbia.
Zsolt HorváthCenter of Oncoradiology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/pore.2022.1610383.].

Indexed as

adjuvant treatmentearly breast cancerguidelineinflammatory breast cancerlocally advanced breast cancermetastatic breast cancerneoadjuvant treatment

Identifiers

PMID36798671
PMCPMC9927865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.